US Congress House Bill 3513 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Democrat 19-0)
Status: Introduced on September 16 2015 - 25% progression, died in committee
Action: 2015-09-18 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Prescription Drug Affordability Act of 2015 This bill amends titles XVIII (Medicare) and XIX (Medicaid) of the Social Security Act to modify provisions related to the affordability of prescription drugs under the Medicare and Medicaid programs. Specifically, the bill: requires the Centers for Medicare & Medicaid to negotiate lower prices on behalf of beneficiaries for drugs covered under Medicare Part D; accelerates closure of the Medicare Part D coverage gap known as the "donut hole," under which beneficiaries who have reached a certain level of yearly drug costs become fully responsible for any additional drug costs up to a certain limit; requires drug manufacturers to issue rebates for prescription drugs dispensed to eligible low-income individuals under Medicare or Medicaid; and expands the application of certain prescription drug rebate requirements under Medicaid to include rebates for generic drugs. The bill also amends the Federal Food, Drug, and Cosmetic Act to: (1) allow the importation by individuals of prescription drugs from Canada and, potentially, other countries; and (2) establish certain conditions on the award of market exclusivity with respect to drugs. Specifically, a drug manufacturer's market exclusivity shall be terminated if the manufacturer commits, or fails to report, a drug-related violation such as misbranding, illegal marketing, or fraud. In addition, the bill amends the Federal Trade Commission Act to: (1) establish restrictions on certain anticompetitive patent settlements known as "pay-for-delay" agreements, which effectively block generic drug competition; and (2) allow the Federal Trade Commission to initiate proceedings to enforce these restrictions against any parties to such a settlement.

Prescription Drug Affordability Act of 2015

Rep. Elijah Cummings [D-MD]	Rep. Keith Ellison [D-MN]	Rep. Eleanor Norton [D-DC]	Rep. John Sarbanes [D-MD]
Rep. Janice Schakowsky [D-IL]	Rep. Matthew Cartwright [D-PA]	Rep. John Garamendi [D-CA]	Rep. Louise Slaughter [D-NY]
Rep. Hakeem Jeffries [D-NY]	Rep. Marcy Kaptur [D-OH]	Rep. Mark DeSaulnier [D-CA]	Rep. Steve Cohen [D-TN]
Rep. Dina Titus [D-NV]	Rep. Jared Huffman [D-CA]	Rep. Michael Honda [D-CA]	Rep. Earl Blumenauer [D-OR]
Rep. Suzanne Bonamici [D-OR]	Rep. Nita Lowey [D-NY]	Rep. Michelle Lujan Grisham [D-NM]

Date	Chamber	Action
2015-09-18	House	Referred to the Subcommittee on Health.
2015-09-18	House	Referred to the Subcommittee on Health.
2015-09-16	House	Referred to House Judiciary
2015-09-16	House	Referred to House Ways and Means
2015-09-16	House	Referred to House Energy and Commerce
2015-09-16	House	Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2015-09-16	House	Introduced in House

HB2005 (Related) 2015-05-13 - Referred to the Subcommittee on Health.
HB2391 (Related) 2015-05-22 - Referred to the Subcommittee on Health.
HB3061 (Related) 2015-07-20 - Referred to the Subcommittee on Health.
SB31 (Related) 2015-01-06 - Read twice and referred to the Committee on Finance.
SB1083 (Related) 2015-04-23 - Read twice and referred to the Committee on Finance.
SB1364 (Related) 2015-05-18 - Read twice and referred to the Committee on Finance.
SB2023 (Same As) 2015-09-10 - Read twice and referred to the Committee on Finance.

Type	Source
Summary	https://www.congress.gov/bill/114th-congress/house-bill/3513/all-info
Text	https://www.congress.gov/114/bills/hr3513/BILLS-114hr3513ih.pdf